Imanis Life Sciences offers engineered tumor model cell lines for oncology research with xenograft and syngeneic models across leukemia, lymphoma, myeloma, melanoma, and solid tumors. All models have stable, integrated, luciferase and / or GFP reporters for in vivo and in vitro tumor tracking, plus quality-checked viability, sterility, identity, and phenotype. Tumor antigen panels feature graded expression of key TAAs, such as CD19 and BCMA, for evaluating targeted therapies. Custom cell lines and technical support from the scientists who build our product cell lines are also available.